Ambivalence and its influence on participation and non-participation in screening for colorectal cancer by Oster, Candice et al.
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
This is the authors’ version of an article published in 
Qualitative Health Research. The original publication is 
available by subscription at: 
http://qhr.sagepub.com
doi 10.1177/1049732313501890 :
Please cite this article as: 
Oster C, Zajac I, Flight I, Hart E, Young G, Wilson C, Turnbull 
D (2013) Ambivalence and its influence on participation and 
non-participation in screening for colorectal cancer. 
Qualitative Health Research 23(9): 1188-1201.
Copyright (2013) SAGE.
 Please note that any alterations made during the 
publishing process may not appear in this version. 
1 
 
Abstract  
Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, and an ideal target 
for early detection and prevention through cancer screening. Unfortunately, rates of 
participation in screening are less than adequate. In this study we explored why people who 
were offered a fecal immunochemical test for CRC decided to participate or not, and what 
influenced them to take action and complete the test. We conducted 4 focus groups and 30 
telephone interviews with 63 people. The main reason for deciding to screen or not was 
“wanting to know” their CRC status, which operated on a continuum ranging from wanting to 
know, through varying degrees of ambivalence, to not wanting to know. The majority of 
participants expressed ambivalence with regard to CRC screening, and the main cue to action 
was the opportunity to screen without being too inconvenienced. 
Key words 
Cancer, screening and prevention; focus groups; interviews; qualitative analysis; risk, 
perceptions; self-care 
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Colorectal cancer (CRC) is a significant global health problem. It is one of the most prevalent 
cancers worldwide, and the third most commonly diagnosed cancer in men and the second in 
women in developed countries (Jemal et al., 2011). In Australia, CRC is the second most 
commonly diagnosed cancer in both men and women, although men have higher rates of 
incidence than women (Australian Institute of Health & Welfare, 2008). It is also the second 
most common cause of cancer-related death in Australia (Australian Institute of Health & 
Welfare, 2012). The incidence of CRC increases with age; around 93% of people diagnosed in 
Australia are aged 50 or older (Australian Institute of Health & Welfare, 2012). 
Screening is an effective means of reducing the incidence of death from CRC (Australian 
Institute of Health & Welfare, 2012), and population-based bowel cancer screening has been 
introduced in a number of countries (Benson et al., 2008). In the Australian context, as in many 
countries, screening begins with testing a sample of feces for minute traces of blood, which is an 
indication of CRC risk but can be caused by other factors. The test does not detect CRC itself, 
and individuals returning a positive screen are then referred for diagnostic evaluation, usually by 
colonoscopy. The most recent Cochrane systematic review of CRC screening reported an overall 
reduction in mortality of approximately 25% (adjusting for nonattendance to screening), and a 
false-positive rate of approximately 80%, which can lead to adverse psychosocial and 
physiological consequences (Hewitson, Glasziou, Watson, Towler, & Irwig, 2008). The review 
included studies using fecal occult blood test (FOBT) technology for testing for CRC risk, and 
the authors conclude that the results “provide further support for the use of FOBT as a 
population-screening modality to reduce CRC mortality” (p. 1546).  
In Australia, the National Bowel Cancer Screening Program (NBCSP) was introduced in 
2006 with the aim of reducing the incidence of, and mortality due to, CRC. The program uses a 
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fecal immunochemical test (FIT) technology for detection of occult blood (Australian Institute of 
Health & Welfare, 2012). FIT is now the preferred FOBT technology because of its superior 
acceptability and capacity to detect cancer (Young, 2009). Currently the NBCSP sends FIT kits 
to people turning 50, 55, 60, 65, and 70 years, although at the time of the study kits were sent to 
those turning 50, 55 and 65. The test is completed at home and posted to a central pathology 
laboratory for analysis.   
Screening participation rates through the NBCSP are lower than ideal, with the most 
recent figures reporting a participation rate over the period July 2008 to June 2011 (Phase 2) of 
38.4% (Australian Institute of Health & Welfare, 2012). Issues with uptake have also been 
reported in other countries (Levin et al., 2011). It is important, therefore, to understand how 
people make the decision to participate or not participate in CRC screening, and what influences 
them to take action. 
Literature Review 
Previous research has explored people’s knowledge, attitudes and beliefs about CRC, and 
facilitators and barriers to screening. Quantitative research in this area has identified a range of 
demographic characteristics associated with screening for CRC, including gender, age, 
socioeconomic status, and ethnicity (Javanparast et al., 2010; Vernon, 1997; Ward et al., 2010), 
in addition to knowledge about and attitudes toward CRC and screening (Gregory et al., 2011; 
Janz et al., 2007; Vernon, 1997). Health motivation has also been reported to be a significant 
influence on the decision to screen for CRC (Gregory et al., 2011; Vernon, 1997). In a review of 
the literature by Vernon (1997) the author identified that health motivation, or a preventative 
health orientation (illustrated in engagement in other forms of health promotion), was most 
consistently positively associated with screening and was also a differentiating factor between 
persistent compliance with screening and persistent refusal.  
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Risk perception has been found in some studies to influence the decision to screen for 
CRC (Vernon, 1997). For example, Lipkus et al. (2000) found that baseline absolute risk did not 
predict screening intentions whereas greater perceived absolute risk, comparative risk and 
concerns at follow-up were predictive of thinking about, or planning to get, an FOBT. 
Paradoxically, in the UK CRC Screening Pilot Evaluation Team’s (2003) evaluation of the 
United Kingdom screening pilot, perceived susceptibility was not found to be associated with 
screening. Similar results have been reported in other studies (Madlensky, Gallinder, 
McLaughlin, & Goel, 2003). Other influential variables include knowing someone with cancer or 
CRC (Vernon, 1997), provider recommendation and family history of CRC (Costanza et al., 
2005). 
A number of barriers to CRC screening have also been identified, including individual 
barriers, provider barriers and system barriers (Walsh, 2005). Individual barriers include lack of 
knowledge about CRC and screening, and negative attitudes toward screening (Janz et al., 2007; 
Jones et al., 2010), procrastination (Janz et al., 2007; Vernon, 1997; Worthley et al., 2006), lack 
of perceived susceptibility (Vernon, 1997; Worthley et al., 2006), fear of having cancer or not 
wanting to know about health problems (Arveux et al, 1992; Vernon, 1997), and procedural 
barriers such as possible embarrassment, pain, discomfort and the perceived unpleasantness of 
the test (Cole et al, 2011; Janz et al., 2007; Jones et al., 2010; Vernon, 1997). Procedural barriers 
were identified in The UK CRC Screening Pilot Evaluation Team’s (2003) report as the most 
significant factor affecting uptake of CRC screening. An Australian study of why people refuse 
screening for CRC also found individual barriers, including procrastination, unpleasantness of the 
test and lack of symptoms, to be significant barriers (Worthley et al., 2006).   
Research from the United States has identified provider barriers, such as lack of 
recommendation or negative attitudes toward CRC screening by health care providers, and 
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system barriers such as lack of health care coverage for CRC screening, as major obstacles to the 
uptake of screening (Costanza et al., 2005; Jones et al., 2010). According to Vedel et al. (2011) in 
their systematic review of the literature (where most of the studies were conducted in North 
America and Europe) the most frequently reported barriers to CRC screening were lack of 
provider recommendation, embarrassment, fear and discomfort on behalf of the patient, and the 
lack of health care coverage for screening tests. 
Qualitative research has generally supported the quantitative findings on the importance 
of individual, provider and system barriers and facilitators to CRC screening (Brouse et al., 2003; 
Chapple, Ziebland, Hewitson, & McPherson, 2008; Garcia et al., 2011; Green et al., 2008; 
Wackerbath, Peters, & Haist, 2005; Weitzman, Zapka, Estabrook, & Goins, 2001). Qualitative 
research has also revealed barriers to and facilitators of CRC screening not reported in the 
quantitative literature, by delving more deeply into people’s experiences and perceptions, and 
exploring cultural and social aspects of the CRC screening experience. For example, trust (Jones, 
Devers, Kuzel, & Woolf, 2010; Lasser, Ayanian, Fletcher, & Good, 2008) and being a “good 
citizen” (Chapple et al., 2008) have been found to influence CRC screening. 
The influence of culture and gender on screening participation have also been 
qualitatively explored (Javanparast et al, 2012; Severino et al., 2009). Misperceptions of CRC 
and CRC screening underpinned by participants’ cultural background were found in Goldman, 
Diaz and Kim’s (2009) study of perspectives on CRC risk and screening among Dominicans and 
Puerto Ricans in the United States. The authors report that the most commonly mentioned cause 
of CRC was anal sex, and barriers to screening included stigma, misperceptions, embarrassment 
and machismo. Molina-Barcelo, Salas Trejo, Peiro-Perez and Malaga Lopez (2011) found that 
Spanish women were motivated by the importance of self-care and early detection, with the aim 
of preventing personal and family suffering, whereas men were encouraged by their partners. 
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Gender differences in reasons for nonparticipation were also found; women found the test 
unpleasant and feared the results while men “showed carelessness and lack of concern” (p. 669).  
Despite the growing body of qualitative research in this area, there remains a gap in 
understanding the reasons why some people appear to be able to surmount what seem to be 
significant barriers to screening. Another gap in the literature is an understanding of why some 
people who agree to screen for CRC fail to take action, while others follow through on their 
intentions. Furthermore, much of the existing research is based in the United States, with 
relatively few Australian studies found. This is a significant gap in the literature because of major 
differences in health care systems between countries, and the impact these systems have on 
screening participation. In particular, financial concerns have been shown to be a major barrier to 
screening in the American studies, whereas Australia’s public health care system means that this 
barrier is unlikely to be significant. There are also differences in the nature of the screening 
programs offered in different countries.  
Our Australian study aimed to build on existing literature on the decision to screen for 
CRC and address the gaps identified above. In particular, we explored why people who were 
offered a FIT decided to screen or not to screen, and what influenced some of them to take action 
and complete the test despite the barriers widely documented as impacting participation. We 
explored the decision to screen and screening behavior separately based on research suggesting 
that there is often a gap between intention and behavior (Webb & Sheeran, 2006), with intentions 
explaining on average only 28% of the variance in future behavior (Sheeran, 2002).  
Methods 
The analysis reported here formed the qualitative aspect of a randomized controlled trial. The 
trial tested whether personalized and online decision support, tailored on psychological variables, 
resulted in better participation in CRC screening than non-tailored online and traditional paper 
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based resources (Authors, 2010). The participants (n=3408) were recruited from a randomly 
selected sample of men and women identified from the Australian electoral role, and randomized 
to tailored, non-tailored and control groups. All trial participants completed a baseline survey 
exploring variables from the Preventive Health Model as well as decision “stage” using the 
Precaution Adoption Process Model. Participants allocated to the tailored group were also given 
online feedback tailored to their responses. Trial participants were invited to screen for CRC and 
sent a FIT by post, accompanied by either paper-based bowel cancer information (control group), 
or access to information via the online tool. They were asked to complete the FIT within a 
specified time frame and send it to a laboratory (using a pre-paid postage pack) for analysis. 
Eligibility criteria for the randomized controlled trial included: aged between 50 and 75 years; 
access to the internet at some location (because the decision support system was internet based); 
and having not undertaken FIT screening in the preceding 12 months. The age range was selected 
to reflect the target population for CRC screening. 
In order to explore decision-making around CRC screening, we conducted focus groups 
and interviews with 63 participants from the randomized controlled trial who had been sent a 
FIT, including 43 screeners and 20 nonscreeners. We use the term “screeners” to describe those 
participants who participated in CRC screening by returning their completed FIT, and 
“nonscreeners” to describe those participants who failed to return the completed kit within the 
specified time frame (12 weeks). The term “participant” refers to participants in the interviews 
and focus groups. Ethics approval for the trial, including the qualitative component, was sought 
and granted by the relevant ethics committee. Participants were assured of their confidentiality 
and that no identifying information would be presented in any outcomes of the study. 
Recruitment and Sampling Framework 
Interview and focus group participants were purposively recruited from participants in the 
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randomized controlled, and sampled using a maximum-variability sampling framework (Grbich, 
1999). Interview participants were chosen based on a selection matrix of: completion of FIT, 
gender, and age group. These factors were chosen to ensure that the views of both screeners and 
nonscreeners were included, and that the sample was heterogeneous with regards to age and 
gender. Participants were selected with a view to meeting the recruitment goal of 30 participants. 
Focus group participants were recruited to explore their perceptions of the usability and 
acceptability of the decision support tool (these data are not reported here), and participants were 
chosen based on a selection matrix of: randomization; completion of FIT; gender; and age group. 
Participants were selected with a view to meeting the recruitment goal of 30 participants. We 
anticipated that we would recruit more screeners than nonscreeners for the interviews and focus 
groups given that there were fewer nonscreeners in the overall sample of participants in the 
randomized controlled trial. 
Using a list of all participants in the randomized controlled trail, potential participants 
were telephoned by one of the authors and invited to participate in a focus group or telephone 
interview. As each selection criterion was met, the list was scanned for the next person who 
fulfilled an unmet criterion. Sixty-three (63) people agreed to participate (43 screeners and 20 
nonscreeners), 30 in the telephone interviews and 33 in the focus groups. Sixty-five (n=65) 
people refused to participate, of which 27 (41.5%) were nonscreeners. The main reasons given 
for refusal were: too busy with work and other commitments, illness, and not interested in being 
involved. Thirty-five (n=35) men and 28 women agreed to participate. The majority of the 
participants were aged between 55 and 64 (56%), with 19% aged 50-55 and 25% aged 65-70+. 
The participants were mainly employed, either full-time (37%) or part-time (16%), with 43% 
retired. 
Data Collection 
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We conducted 4 focus groups and 30 telephone interviews. Telephone interviews were conducted 
with 16 screeners and 14 nonscreeners, and 27 screeners and 6 nonscreeners participated in the 
focus groups. Semistructured interview guides for the telephone and focus group interviews were 
developed with the aim of exploring the decision to screen or not to screen for CRC. The 
interview guides focused on the reasons for the decision, and the influence of others on their 
decision. Particular issues were explored within these domains. These were based on the 
facilitators and barriers identified in previous research including; the perceived efficacy of 
screening, possible concerns about the test results, procedural barriers with regard to the FIT, 
health perceptions, thoughts on cancer, and participants’ perceived risk of cancer. Participants 
were also asked to discuss any other issues relating to CRC, screening and their decision-making, 
and the open-ended nature of the interview guide encouraged the participants to express their 
own views and experiences. 
Six pilot telephone interviews were conducted to refine the interview guide, and a few 
minor changes were made before proceeding with the data collection. The pilot interviews were 
included in the analysis. The telephone interviews were conducted between May and June 2011, 
and the average duration of the interviews was approximately 30 minutes. The interviews were 
conducted by one of the authors who worked as a project officer on the randomized controlled 
trial. 
A different interview guide was developed for the focus groups because we wanted to 
explore in detail the participants’ perceptions of the usability and acceptability of the decision 
support tool (this analysis will be published separately); however the focus group guide also 
incorporated the questions used in the telephone interviews and these data were included in the 
analysis presented here. There were 8 participants in focus group 1, 10 in focus group 2, 8 in 
focus group 3, and 7 in focus group 4. The focus groups were conducted by a research consultant 
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not connected with the study in a consumer testing laboratory at a local research organization. 
Participants were encouraged to discuss issues freely and express divergent views. Issues raised 
that were outside of the interview guide were pursued. All participants were invited to enter into 
the discussions. The focus groups took place in September 2011 and were around 2 hours in 
duration. The focus group participants were compensated for their time and travel ($50). 
Data Analysis 
The interviews and focus groups were audio-taped and transcribed verbatim. We used a 
framework analysis approach to analyze the data. Framework analysis is a qualitative method of 
analysis that is specifically suited to applied research that has specific questions, a limited 
timeframe, a predesigned sample, and a priori issues that are to be explored, such as those 
identified in existing literature (Strivastava & Thomson, 2009). Framework analysis does, 
however, provide the additional capacity to identify and examine emergent themes and ideas 
(Strivastava & Thomson, 2009; Lipstein et al., 2010).  
Framework analysis has been used previously to explore CRC screening (Green et al., 
2008), and the analytic processes are similar to other forms of thematic analysis commonly used 
in qualitative research in this area (Weitzman et al., 2004). Framework analysis involves a 5-step 
process: familiarization with the interviews and transcripts to gain an overview of the data and 
note any key ideas and recurrent themes; identifying a thematic framework, using both a priori 
and new themes arising from the data; indexing, where portions or sections of the data that 
correspond to a particular theme are identified; charting, where indexed pieces of data are 
arranged in charts of the themes; and mapping and interpretation, which involves analysis of the 
key characteristics as laid out in the charts (Strivastava & Thomson, 2009).  
Charting is one aspect of framework analysis that is different to other forms of thematic 
analysis, and offers important advantages. It involves presenting the data in tables with the 
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themes on the vertical axis and participants on the horizontal axis. Quotes from the interviews are 
presented for participants under each theme. Charting provides a visual display of the data to 
facilitate comparisons between participants and the exploration of negative cases, and ensures 
that the analysis is based firmly in participants’ views. It also provides a transparent means of 
sharing the data with other researchers for group discussion. The charts form a basis for the final 
stage of mapping and interpretation, the aim of which is to define concepts, explore and map the 
range of phenomena, create typologies, find associations, provide explanations and develop 
strategies, all of which are grounded in the data and reflective of the attitudes, beliefs and values 
of the participants (Strivastava & Thomson, 2009).  
We used the online qualitative data analysis software, Dedoose (Version 4.3.86, 2012) to 
assist the data analysis process. Dedoose was chosen over other qualitative analysis software, 
such as NVivo, as the online format allowed all of the researchers to work on the analysis using 
the same data set. We began by developing codes and grouping similar codes into themes. 
Themes were identified on the basis of patterned responses or meaning within the data set that 
“capture[d] something important about the data in relation to the research question” (Braun & 
Clark, 2006, p. 82). Thus patterned responses in relation to participants’ discussions about why 
they decided to screen or not to screen, and what influenced screeners to take action and complete 
the test, were collated. The analysis initially focused on a priori issues based on the interview 
guides (such as “risk perception” and “influence of others”). After further exploration we 
identified a number of emergent themes (such as “wanting to know”, “ambiguity” and “self 
care”), which were incorporated into the thematic framework. The development of the initial 
codes and themes was carried out by one of the authors who was not involved in the randomized 
controlled trial, and who had no previous knowledge or experience with CRC or screening. Once 
the thematic framework was identified, indexing of the codes was undertaken.  
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At this stage the decision was made to test the reliability of the coding framework using 
the multi-rater Kappa measure of agreement through the facilities made available by Dedoose. 
We recognize that the concept of inter-rater reliability is a controversial one in qualitative 
research (Pope, Ziebland, and Mays, 2000), particularly with regard to concerns that a reliability 
assessment of a predefined list of themes will limit the inductive nature of data analysis by 
closing the process to additional induction once a coding framework is confirmed (Cook, 2011). 
However, we felt that it was useful to check that we all understood what the initial codes were 
representing, and that there was consistency across the ways in which we interpreted the 
participants’ comments. To test for inter-rater reliability, four interviews were indexed using the 
coding framework, and the same interviews were then independently indexed by two others using 
the same coding framework. Kappa scores of 0.96 and 0.98 were achieved, showing good inter-
rater reliability. Differences were discussed and any issues with the coding resolved before the 
rest of the transcripts were coded. We were mindful of the importance of the induction process 
continuing throughout the analysis, and the codes were refined and reorganized as the analysis 
process continued. 
Once the interview transcripts were coded we charted the themes and undertook the final 
stage of mapping and interpretation. All of the authors were involved in the analysis and 
meetings were held to discuss the themes and resolve issues, using the charts as a visual display 
of participants’ views. To help with the final stage of the analysis, we followed Braun and 
Clarke’s (2006) suggestion of asking a number of questions of the data, such as: What does this 
theme mean? What assumptions underpin it? What are the implications of this theme? What 
conditions might have given rise to it? Why do people talk about this thing in this particular way 
(as opposed to other ways)? What is the overall story the different themes reveal about the topic? 
(p. 94). 
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Rigor 
A number of processes were used to ensure analytic rigor (Shenton, 2004). These included the 
use of both interview and focus group methods of data collection, negative case analysis, frequent 
debriefing sessions to discuss the analysis, and ensuring the involvement of researchers with no 
previous knowledge and experience with CRC and screening. We included both screeners and 
nonscreeners in the research in order to ensure a variety of perspectives on decision making 
around screening. We have described the context of the research and detailed the methods of data 
collection and analysis. In what follows we present a rich description of the analysis using 
multiple examples from the interview transcripts and ensuring that the views of all participants 
are represented. 
Results 
Nearly all of the participants (98%) had decided to screen for CRC in response to the invitation to 
participate in the randomized controlled trial, although not all of the participants (32% 
nonscreeners) followed through on this decision. We begin with a discussion of the decision to 
screen for CRC, followed by an exploration of what motivated the screeners to follow through on 
their decision. Only information on participants’ screening status is included alongside quotations 
to maintain their anonymity. 
The Decision to Screen for CRC  
The participants discussed a range of reasons for making the decision to screen for CRC. 
Underlying these we found a central thread running through the discussions, namely “Wanting to 
Know” their CRC status. We begin with a discussion of the concept of “wanting to know”, where 
we present respondents’ views of why they agreed to be sent the FIT and screen for CRC. We 
then explore the notion of ambivalence, where we propose that while the participants expressed a 
desire to know their CRC status, ambivalence was evident in the strength of their conviction and 
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the relative importance of screening. 
Wanting to know. Both screeners and nonscreeners discussed the value of screening in terms of 
providing them with knowledge of their CRC status. More specifically, while the participants 
generally understood that the FIT was only the first step in the process to diagnosis, they 
described the FIT as a means by which to find out whether or not they had bowel cancer. As one 
of the focus group participants commented with regard to why he had done the FIT, “. . . it was 
for my own wanting to know if I’ve got it [CRC]” (Screener). Screening with the FIT was 
described as a “safety check” (Screener), a way of checking on their health status while they still 
felt healthy and in the absence of symptoms, “. . . my health is pretty good at the moment. As I 
say it just helps you to know what’s going on with your body” (Screener). 
Wanting to know their CRC status extended to participants’ thoughts about how they 
might respond to the results. Although many participants discussed feeling concerned or anxious 
about the results (one of the barriers to screening identified in the research literature), the 
majority reported that they would rather know than not know, irrespective of whether the results 
were positive or negative. Wanting to know was also described as overcoming concerns about the 
test itself, which involves taking a sample of feces. Some participants were concerned about 
doing the FIT because they found the test “gross” (Nonscreener) or did not like the idea of 
“playing with poo” (Nonscreener) - another reported barrier to screening. However, for the most 
part, the participants were able to overcome their discomfort because they wanted to know their 
CRC status. 
The participants outlined two advantages of knowing their CRC status. First, if the results 
were negative for blood, the FIT was seen to offer reassurance by indicating that they did not 
have CRC, for example, “It’s nice to know I’m clear for a few years anyway” (Screener). Second, 
if the result was positive for blood, the FIT was described as providing early detection to improve 
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participants’ chances of survival if they did have CRC. As one participant put it, “No-one wants 
to know they’ve got cancer but I think most of us would want to know as soon as possible so 
something if possible can be done”  (Screener). 
Not wanting to know. The participants also discussed “not wanting to know” in relation to CRC. In 
most cases they were hypothesizing about why other people might decide not to screen. For 
example, in response to the discussion of a friend who chose not to engage in any form of cancer 
screening, a participant stated: “It’s difficult because that’s her right. It’s her right not to know” 
(Nonscreener). Another participant discussed her feeling that some people wish to remain 
oblivious to their cancer status: “And the disadvantage [of screening], for some people, not for 
me, but for some people is that they really don’t want to know” (Nonscreener). 
There were only two nonscreeners who identified that they, personally, would rather not 
know their CRC status, and that this was the primary reason for the decision not to complete the 
FIT. Their main concern was in relation to what might happen in the aftermath of finding out 
they have CRC, particularly with regard to treatment. For one nonscreener, her decision not to 
know related to her experience of watching her mother die of cervical cancer: 
I don’t participate in any type of screening. . . . I watched my mother die an absolutely 
horrible death as a result of all the treatment she had for cervical cancer and I vowed and 
declared at that time that I would rather not know about it, thank you very much. 
(Nonscreener) 
 
The other participant expressed similar concerns about negative effects of cancer treatment. 
These two nonscreeners were unusual in their discussion of not wanting to know their 
CRC status; the majority of participants, including nonscreeners, wanted to know and made the 
decision to do the FIT. Given the centrality of wanting to know as expressed by the participants, 
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this raises the question of what it is that underpins this desire. In our analysis we found that 
wanting to know was underpinned by notions of self-care and the importance of taking personal 
responsibility for one’s health. 
Screening as self care. Both screeners and nonscreeners described CRC screening as a form 
of self-care, and the participants viewed themselves as being health conscious individuals who 
take care of their health: “. . . it’s taking care of your heath really” (Screener). Screening for CRC 
and other cancers also allowed the participants to take personal responsibility for their health: “. . 
. you’ve got to take a bit of responsibility for your own health” (Screener). The importance of 
taking personal responsibility for their health was reinforced by the insistence that the decision to 
test for CRC was a personal decision, an “individual thing” (Screener), rather than relying on the 
expectations of others, such as family or peers. The view that other people have no influence on 
the decision to screen for CRC was expressed quite strongly by nearly all of the participants.  
Contrary to the research literature, health professionals, too, were not considered a major 
influence on the participants’ decision to screen. Participants discussed how they had made the 
decision despite the fact their doctors had not suggested that they do the FIT, emphasizing that 
the decision to screen is a personal one: “. . . I haven’t spoken to a health person at all, I’ve just 
put a decision on myself for whatever reason to say yes [I will do the FIT]” (Screener). In fact, 
some participants stated that they had done the FIT despite their doctors suggesting that they 
should not do the test:  
I asked my doctor [if I should screen for CRC], she said ‘no you haven’t got a history’ 
blah, blah, blah; however you know I heard around of friends having . . . bowel cancer 
and I wanted to do it, so it was really my decision. (Screener)  
 
In this section we have explored “wanting to know” as underpinning the decision to 
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screen for CRC, and the importance of self-care and personal responsibility in participants’ 
wanting to know their CRC status. In the following section we discuss ambivalence about the 
screening decision, the impact of ambivalence on procrastination and the ability of participants to 
ultimately follow through on their decision to screen for CRC, and the role of risk perception in 
ambivalence. We use the term “ambivalent” to mean a lack of conviction or certainty with regard 
to the desire to know (or not to know) their CRC status.  
Ambivalence about the screening decision. As discussed earlier, nearly all of the participants made 
the decision to receive a FIT to screen for CRC because they wanted to know their CRC status. 
However, we found that in most cases the desire to know was not expressed as an important or 
urgent desire. Only a few participants expressed a strong conviction about wanting to know 
whether or not they had CRC, such as: “. . . not knowing, is not . . . really an option in my 
opinion . . . ” (Screener). Similarly, not wanting to know was a desire strongly expressed by only 
two nonscreeners. As one of these participants stated: “I would rather not know about it, thank 
you very much” (Nonscreener).  
For the majority of participants, both screeners and nonscreeners, the decision to do the 
test was expressed in more ambivalent terms such as “why not?” (Screener), “there’s no real 
reason not to” (Screener), and “it doesn’t hurt to screen” (Screener). One nonscreener explained 
her decision to do the FIT in similarly ambivalent terms: “I just thought it would be nice to know 
that you haven’t got a problem down in your bowels” (Nonscreener). These participants can be 
described as wanting to know their CRC status, yet ambivalence can be seen in the apparent lack 
of conviction or certainty regarding the importance of screening.  
It appears, therefore, that “wanting to know” did not function simply on an “either-or” 
basis, with screeners wanting to know and nonscreeners not wanting to know their CRC status. 
Instead, we propose that “wanting to know” operated on a continuum based on the strength of 
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participants’ conviction. This continuum ranged from a strong conviction about “wanting to 
know” (it was extremely important to find out their CRC status), through a more ambivalent 
position (being prepared to engage in screening but not necessarily considering it to be 
important), to a strong conviction about not wanting to know at the other end of the continuum. 
For those participants with a strong desire to know, following through on the decision to screen 
was relatively easy, while for those who expressed varying degrees of ambivalence the ability to 
follow intention with action was more difficult. 
Ambivalence and procrastination. Ambivalence in the screening decision was reflected in 
procrastination about following through on the decision to screen. Although a small number of 
nonscreeners were unable to do the test because of significant life events (such as caring for a 
dying relative), or having to have a colonoscopy (negating the need for the FIT), procrastination 
was the main reason given by nonscreeners for not taking action despite making the decision to 
screen. For example, one nonscreener who had been overseas periodically during the period of 
the randomized controlled trial initially gave this as his reason for not doing the FIT, but then 
went on to state: “It should have been a matter of urgency. I must have a degree of 
procrastination in me not to seize the moment in between those trips and get this done” 
(Nonscreener). Similarly, one of the focus group participants initially stated that her reason for 
not following through on her decision to screen was that she was caring for a friend who 
subsequently died of CRC, and that she was then busy and sick, but went on to say: “Actually 
that’s probably not true. It’s probably due to that ‘come on you know you’re supposed to have 
had one’, so yeah” (Nonscreener).  
Procrastination was an issue for screeners as well. In fact, taking immediate action 
following the decision to screen was a straightforward process for only a few of the screeners 
whose desire to know their CRC status was strong enough for them to make screening a priority. 
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For the majority, though, there was a degree of procrastination involved before they were able to 
prioritize the test and get it done: 
No I didn’t do it quickly. I put it on the side and thought I’d do it later and then I think I 
got a reminder that I hadn’t done it and so then I did it. (Screener)  
 
Some screeners had procrastinated on testing in the past, describing how they still had unused 
FOBTs in their cupboards that had been given to them by their doctors.  
Ambivalence and risk perception. Risk perception played an important role in the 
participants’ level of conviction about wanting to know their CRC status. Risk was discussed in 
terms of age, having a family history of bowel cancer, and having a personal history of other 
forms of cancer. Some participants saw themselves as being at risk of CRC: “Yeah, I’m in that 
sort of age group that’s more likely than not [to get CRC] . . . ” (Screener). Some expressed 
ambivalence with regard to whether or not they were at risk. For example, discussing an absence 
of risk factors and stating “. . . but you never know” (Screener), or “… but that doesn’t mean 
anything I suppose” (Nonscreener). Others did not see themselves as being at risk, or described 
mitigating factors that lessened their perceived risk, such as leading a healthy lifestyle, eating 
well and having a positive attitude. One participant expressed this belief as: “Well I’m certainly 
more aware of [CRC] and I take care of myself in a better way. I look after my diet, I keep myself 
relatively healthy . . . ” (Screener).  
A lack of perceived risk or ambivalence about risk reduced the importance of screening 
for participants despite agreeing to do the FIT: “I guess if I was worried about my health that 
would motivate me to move it [doing the FIT] up my list of jobs to do. But that’s not really a big 
factor” (Nonscreener). Yet even for those who viewed themselves to be at risk, ambivalence was 
still evident. For example, a woman whose sister died of CRC explained her decision to screen as 
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follows: 
Oh I think [screening is] very advantageous, because as I said there’s so many cancers 
going around and you never know what you’ve got. My sister died of colon cancer, so 
you think “Well cancer’s in the family, it doesn’t hurt [to screen]”. (Screener) 
 
Here we see a lack of conviction or certainty in the decision despite having a family history of 
CRC, evident by the phrase “it doesn’t hurt [to screen]”. A nonscreener described the importance 
of screening due to her family history, yet still did not follow through on the decision to screen: 
“Because I am a cancer sufferer . . . I was very interested in completing this bowel cancer 
screening because my mother actually died of bowel cancer” (Nonscreener). This suggests that 
awareness of risk factors might not be enough of a motivator to overcome ambivalence to 
screening and move some people from intention to action. 
Overall, what was interesting about participants’ discussions about risk was that while 
there was an awareness of the risk factors associated with CRC, particularly in terms of age, diet 
and family history, these were not necessarily seen as personally relevant. This can be seen in the 
example of a screener who perceived her risks of CRC as being “similar to all women . . . I don’t 
really worry about it, it doesn’t stress me on a day to day basis” (screener), despite having a 
family history of CRC. Age was another risk factor that was not necessarily viewed as personally 
relevant. For example, in one of the focus groups the discussion turned to a question in the 
questionnaire of perceived risk (the questionnaire was filled out as part of the randomized 
controlled trial), and how the participants rate their risk of CRC: 
I have to say I answered no to one of those [questions]. I think it was the question “Do 
you think you’re in a high risk group from getting bowel cancer?” No, other than being 
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over 50, and I mean that’s the whole world that’s over 50 so that’s not a high risk group 
that’s everybody, so my answer was no. (Nonscreener) 
 
This lack of personal relevance in relation to risk may have played a role in participants’ 
ambivalence about screening. 
Another factor in the relationship between ambivalence and risk perception is that instead 
of focusing on their risk of CRC specifically, the participants more often expressed their risk in 
terms of a generalized risk of cancer. For example, in the discussions of age as a risk factor, the 
participants discussed the need to test for lots of diseases as you get older, with bowel screening 
another one to add to the list. When discussing their cancer risks the participants expressed the 
view that cancer is “all a part of our history and biology of the human body” (Nonscreener), “it is 
so common nowadays” (Screener), cancer “is a part of life” (Screener) and “I think probably 
everybody is aware that cancer can happen to anybody” (Screener). For some this perception of 
cancer being prevalent worked to foster a desire to know their CRC status, but had the opposite 
effect on two nonscreeners who expressed a more fatalistic view about their risk of cancer: 
The world is full of chances; you have to take chances as they come. . . . It might happen 
to you, it might not. You don’t know, it’s just like winning Lotto [Lottery], isn’t it? 
(Nonscreener) 
 
I never give [my risk of cancer] a great deal of consideration. I just think it won’t happen 
to me and if it does then it was meant to be and let’s just hope it’s fast and sharp and, a 
fatalistic view, I guess. (Nonscreener) 
 
The above discussion highlights the complexity of risk perception in participants’ decisions about 
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whether or not to screen for CRC, and the lack of a sense of urgency or importance in relation to 
CRC risk and screening. 
The participants discussed a number of influences on their perception of risk for CRC and 
the personal relevance of risk factors. The most common was knowing personally or hearing 
about someone who had bowel cancer, which was described as highlighting the importance of 
screening for CRC and thus decreasing ambivalence. The media also influenced participants’ risk 
perception, as can be seen in the following extract: “. . . my doctor’s never suggested I have [a 
FIT] either, so if it’s not coming from the general media, newspaper, TV or radio then . . . the 
awareness isn’t there” (Screener). The media was even influential in persuading the participant 
who stated that she did not want to know her CRC status (because of her experience of watching 
her mother die of cancer) to do the FIT: “In hindsight it was the wrong decision to make. When I 
read the follow up data on the TV and newspaper I felt that it was very remiss of me not to have 
done [the FIT]” (Nonscreener). Thus in this case the media portrayal of the importance of 
screening for CRC moved the participant towards the “wanting to know” end of the end 
continuum. 
In this section we have proposed that ambivalence about screening is one possible 
explanation for why it was that although both screeners and nonscreeners had decided to screen, 
not everyone followed through and did the FIT – in other words, screening for CRC was not 
considered important or relevant enough to make it a priority. This raises the question of what is 
required for participants to follow through on their decision to screen and take action, particularly 
because there is evidence that a medium-to-large change in intention leads only to a small-to-
medium change in behavior (Webb & Sheeran, 2006). Research certainly identifies cues to action 
- stimuli that help bridge the gap between intention and behavior - as critical to the 
transformation of intention to action (Flight, Wilson, & McGillivray, 2012). In what follows we 
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address the second focus of our analysis, namely an exploration of what motivated the screeners 
to follow through on their decision to screen for CRC, despite their apparent ambivalence toward 
screening. 
Taking Action 
We identified three cues to action in participants’ discussions that motivated the screeners to 
follow through on their decision to screen, namely convenience, opportunistic screening, and 
making a commitment to follow through on the decision to screen. These cues appeared to be 
effective because they supported participants to undergo screening despite a lack of conviction 
about wanting to know their CRC status. 
Convenience and opportunistic screening. For the participants who followed through with the FIT, 
despite expressing ambivalence about screening, an important cue to action was being provided 
the chance to screen in a way that caused them the least inconvenience: 
. . . it was free and it was being done for me so I didn’t kind of have to head off to the 
doctor or anything like that and it was actually being set up for me. (Screener) 
 
The importance of the FIT being free and sent to people’s homes, rather than having to go to a 
doctor or pharmacy to get a test, was also discussed at some length in the focus groups. 
Being provided the opportunity to screen through participation in a screening program or 
research study was another cue to action for the participants. Some participants spoke of wanting 
to do the FIT prior to the invitation to participate in the randomized controlled trial, but not 
following through and getting the kit themselves. Being invited to participate in the study was 
therefore a good opportunity for them to do the FIT: 
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. . . I seized the opportunity when I got it because . . . I was hoping that I would get one 
[through the national screening program], but I didn’t actually go to my doctor and say ‘I 
think I should have a test at my age because I’ve never had one’. (Screener) 
 
I heard that [the Australian government were] going to stop the testing and so I thought 
this was an opportunity to get tested before they stop. Just the opportunity was there so I 
decided to take it. (Screener) 
 
In other words, while the participants might have wanted to know their CRC status, the desire to 
know was not strong enough for them to seek out a screening test, and they would rather wait for 
the opportunity to present itself. The importance of being given the opportunity to screen through 
the participation in a screening program or research study, rather than actively seeking a 
screening test, was also discussed by a nonscreener who still wanted to do the test. He stated: 
“Given the opportunity to do it again I think I wouldn’t have any hesitation to do it now” 
(Nonscreener). In fact nearly all of the nonscreeners expressed the desire to do the test, but were 
noncommittal when told they could get a test from their doctor or pharmacy rather than wait for 
another opportunity to come their way.  
The emphasis on convenience and opportunistic screening was evident even when 
participants perceived themselves to be at risk and viewed screening as an important part of 
taking responsibility for their health. Similarly, those participants who had previously screened 
for CRC (generally through the Australian government’s screening program) and wanted to 
participate in ongoing screening viewed being sent the FIT as a useful reminder of the need to 
continue to screen: 
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I mean it’s the second time I’ve done it, I got one for my 55th birthday, bowel testing, 
thank you very much . . . And thank you for giving me a nudge to do it again. (Screener) 
 
This same participant discussed how “ease of access” (by being sent a screening test through a 
government funded screening program) helps people in “getting over the hurdle of actually 
getting yourself a kit, working out how to do it and doing it” (Screener). 
All participants had been provided a convenient opportunity to screen by being sent a free 
FIT through participation in the randomized controlled trial, however not all of the participants 
followed through on their decision to screen. We propose that because of ambivalence toward 
CRC screening it might take time for screening for CRC to become a priority in people’s lives, 
highlighting the importance of being provided the opportunity to screen in an ongoing manner. 
This is also supported by the fact that some participants had been provided with screening tests 
by their doctors but had not used the tests: “I had received a kit before and never used it, I just 
left it in the cupboard but when this came along I thought yes I’ll do it” (Screener). 
Making the commitment to screen. The final cue that helped transform participants’ intentions into 
action was making a commitment to do the FIT through participation in the randomized 
controlled trial. This came up particularly in the focus groups, where the participants discussed 
the impact of going through the questionnaire on the study’s website, which had to be completed 
prior to the FIT being sent to them. It appears that taking the time to engage with the website 
acted to both reinforce the decision to screen (which they described as having been made as soon 
as they received the invitation to participate in the study) and bring the test itself closer to the top 
of their priority list: 
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I think [the website] pushed us into doing something about it . . . so probably I think with 
regard to the actual website it sort of perhaps brought it to mind and made you more 
conscious of it to yes, go ahead and do something about it. (Screener) 
 
Engaging with the website was described as making a commitment to follow through and 
complete the test: “Well I made a commitment, I’ll go ahead with it”  (Screener). The value of 
the website as a cue to action is also supported by some of the results of the randomized 
controlled trial (which will be reported elsewhere), where those participants who were allocated 
to the web-based version of the questionnaires and information sheets were more likely to do the 
FIT than those who participated in a paper-based version. 
Discussion 
We identified the main reason for participants deciding to screen for CRC as “wanting to know” 
their CRC status. Previous research on the decision to screen for cancer has also identified the 
importance of wanting to know, or not wanting to know, in this decision. For example, in their 
survey of the factors that influence screening compliance, Arveux et al. (1992) found that the 
main reason for not participating in CRC screening was “not wanting to know more about their 
health status” (p. 574). At the other end of the spectrum, Richardson et al. (2002) found in their 
qualitative study of women’s understanding and experience of DEXA scanning for osteoporosis 
that knowing one’s risk status was “central to participants’ reasoning about DEXA scans” (p. 
122). Self-care and taking personal responsibility for health were important considerations in 
relation to the decision to screen. This has been found in previous research on CRC screening 
(Chapple et al., 2008; Lipworth et al., 2010; Molina-Barcelo et al., 2011), and is consistent with 
social theories related to late modernity, where self management and individualization of 
responsibility have been recognized as central concepts in western industrialized societies 
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(Crawford, 2006; Crawshaw, 2012). However, our research has identified that wanting to know 
one’s cancer status might not necessarily be a simple “yes or no” decision, but rather functions on 
a continuum ranging from wanting to know, through varying degrees of ambivalence, to not 
wanting to know.  
Only a few of the participants in our study expressed strong views on wanting to know or 
not wanting to know their CRC status, with the majority demonstrating an overall ambivalence 
with regard to CRC screening, despite an awareness of CRC risk factors. Ambivalence was seen 
in the participants’ lack of conviction about the importance of screening (using terminology such 
as “why not” and “it doesn’t hurt to screen”) and in their procrastination once the decision was 
made. Ambivalence in the decision to screen for cancer has been reported in other studies 
(Knops-Dullens, N. de Vries, & A. de Vries, 2007; Lipkus & Klein, 2006; Polzer, Mercer, & 
Goel, 2002). For example, Halabi et al. (2000) found that women who were off-schedule for a 
mammography were more likely to be ambivalent about screening mammography. The women in 
Willis’ (2008) Swedish study of mammography screening also expressed ambivalence in the 
decision to attend a mammography. The ambivalence expressed by our participants might result 
from the Australian political and cultural context in which CRC screening is not given a high 
enough priority by government or health professionals (in fact, some of our participants reported 
that their doctors had told them that they do not need to screen for CRC). It may also be a result 
of the two-step screening process adopted in Australia, where individuals test for CRC risk using 
a FIT, followed by colonoscopy. Additional research is needed to explore this insight. 
Our participants indicated ambivalence in both the decision to screen for CRC, and also 
their risk perception with regard to CRC. Similarly, in Willis’ (2008) study of women’s 
participation in mammography screening, where women expressed ambivalence in the decision 
to screen, ambivalence in risk perception was also reported where women expressed low risk but 
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went on to make statements such as “but you never know” (p. 142). Researchers and 
commentators have in fact pointed to the important part played by ambivalence in the 
individual’s response to risk in general (Beck, 2006; Lupton & Tullock, 2002). For example, 
Lupton and Tullock (2002) explored risk epistemologies of a group of Australians, and found that 
contradiction, ambivalence and complexity were apparent in their participants’ accounts of their 
understandings and experiences of risk. Beck (2006) goes so far as to state “Risk is ambivalence” 
(p. 331). Our study adds support to the relationship between risk perception and ambivalence. 
An important issue in relation to risk and ambivalence is the extent to which people view 
risk information as personally relevant (Lipworth et al., 2010). For example, in Mesters, Ausems 
and de Vries’ (2005) study of the general public’s knowledge, interest and information needs 
related to genetic cancer, the authors found that “[n]ot being able to estimate the personal 
relevance of genetic information created feelings of ambivalence, which left most people 
undecided regarding exposing themselves to genetic information” (p. 72). According to Craddock 
Lee (2010), “risk information is rarely taken up as value-neutral objective truth, but . . . is deeply 
subjective, interiorized against a preexisting sense of self” (p. 6). He views this translation of risk 
information as central to understanding ambivalence toward public health efforts like screening.  
The ambivalence expressed by participants might explain why not all of them followed 
through on their decision and did the FIT. Similarly, Constanza et al. (2009) suggest that the 
intention to screen when not coupled with action (in the form of scheduling a mammography in 
their research) “belies an underlying ambivalence or persistent procrastination” (p. 347). This 
suggests that ambivalence might play a role in moderating the relationship between intention and 
behavior, where participants who were more certain about wanting to know their CRC status 
were more likely to follow through on their intention to screen, and vice versa. Research on the 
relationship between ambivalence, attitudes, intention and screening behavior has demonstrated a 
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similar effect. For example, Connor et al. (2002) found that attitudes toward healthy eating were 
more predictive of healthy eating behaviors when ambivalence was lower. Dormandy, Hankins, 
and Marteau (2006) explored the moderating role of ambivalence in the attitude to and uptake of 
a prenatal screening test for Down Syndrome, and concluded that ambivalence might undermine 
the making of informed choices about screening. 
Previous research on barriers to CRC screening has identified a range of barriers, but 
ambivalence has not been specifically discussed. It is possible that ambivalence underpins these 
barriers, as in our study. Potential barriers, such as finding the test unpleasant or fear of the 
results, were overcome by a strong desire to know their CRC status, but a more ambivalent 
attitude resulted in procrastination, which was identified as the main reason for not completing 
the FIT. Previous research has also identified procrastination as a major barrier to CRC screening 
(Janz et al., 2007; McCaffery et al., 2001; Vernon, 1997; Worthley et al., 2006). This relationship 
between ambivalence and procrastination in CRC screening should be explored further. 
Previous research has identified that changing behavioral intentions does not necessarily 
engender behavior change (Webb & Sheeran, 2006), and highlighted the importance of exploring 
and understanding cues to action. Given their ambivalence regarding wanting to know their CRC 
status and procrastination in following through on the decision to screen, the main cue to action 
for our participants was the opportunity to screen without being too inconvenienced (i.e. 
receiving a free FIT kit, delivered to their homes). Similarly, calling women to mammography 
screening and ease of attendance was identified in Willis’ (2008) study as important in 
overcoming women’s ambivalence about screening without being coercive. These findings 
highlight the importance of providing convenient (and free) screening opportunities for target 
populations in an ongoing manner. It may also be that the results are a reflection of the Australian 
health care system, which provides free access to screening for a range of cancers. This may lead 
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to the expectation that screening should be free and initiated by the government. Another cue to 
action was making a commitment to do the FIT through engagement with the website as part of 
their involvement in the randomized controlled trial. The role of personal commitment, and 
commitment to others, has been identified as an important factor in moving people from intention 
to action (Ajzen, Czasch, & Flood, 2009). For example, Elley, Dean and Kerse (2009) found that 
personal commitment and a commitment to others through participation in a physical activity 
intervention motivated people to engage in physical activity. 
In our study the participants were keen to emphasize that the decision to screen with the 
FIT was their decision and not influenced by others, including their health professionals. This 
contrasts with previous research that has highlighted the importance of recommendations from 
health professions in the decision to screen for CRC (Costanza et al., 2005; Holt et al., 2009; 
Jones et al., 2010; Vedel et al., 2011; Zajac et al, 2010). However, the participants did identify 
indirect influences on their decision to screen, such as knowing others with CRC and media 
reports on the topic. This suggests opportunities to noncoercively influence people’s decisions 
around CRC screening in terms of indirect influences such as the media.  
Conclusion 
Our Australian study builds on existing literature on the decision to screen for CRC by exploring 
why people who were offered the FIT decided to screen or not to screen, and what influenced 
them to take action and complete the test. The study highlights the complex relationship between 
risk perception and screening behavior, demonstrating ambivalence to screening among both 
screeners and nonscreeners. This suggests that unless individuals have a sense of personal risk for 
CRC, screening opportunities will need to be as accessible and convenient as possible. 
Limitations 
This is a qualitative, exploratory study and as such is limited in terms of generalizability. More 
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screeners than nonscreeners participated in the study, and it is possible that people who felt 
strongly about not participating in CRC screening might not have wanted to be interviewed. 
Furthermore, the fact that the participants were selected from participants in a randomized 
controlled trial evaluating a decision support tool for CRC screening could have created a bias 
towards “wanting to know” their CRC status. Additional research needs to be done exploring the 
extent to which these findings are applicable more generally, and in particular in other countries 
given the differences in health systems and approaches to screening. 
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